NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

From Dr.Cobbs presentation (Individualized Treatments for Glioblastoma)
on March 14, 2018. (Cranial Conference)
https://www.facebook.com/SeattleScienceFoundation

Dr.Cobbs report on a patient (still alive after 15 years) with glioblastoma who developed an extremely robust human cytomegalovirus (HCMV)-specific CD8+ T-cell response to the pp65 CMV immunodominant epitope that began immediately after one injection of autologous tumor lysate-pulsed DC.(DCVAX-L min. 25)

I think he is talking about this case study:
“Induction of Cytomegalovirus-specific Anti-tumor Immunity after Autologous Tumor Lysate-pulsed Dendritic Cell Vaccination in a Patient with Glioblastoma”
Robert M. Prins, Ph.D., Timothy F. Cloughesy, M.D., and Linda M. Liau, M.D., Ph.D.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775501/